Yuan W, Liu M, Yang D, Shi Y, Wang Z, Cao X
Stem Cell Res Ther. 2025; 16(1):128.
PMID: 40059221
PMC: 11892273.
DOI: 10.1186/s13287-025-04237-1.
Smeijer J, Kohan D, Dhaun N, Noronha I, Liew A, Heerspink H
Nat Rev Nephrol. 2024; 21(3):175-188.
PMID: 39643698
DOI: 10.1038/s41581-024-00908-z.
Scott J, Moutchia J, McClelland R, Al-Naamani N, Weinberg E, Palevsky H
Am J Respir Crit Care Med. 2024; 210(8):1045-1056.
PMID: 38820270
PMC: 11531102.
DOI: 10.1164/rccm.202311-2196OC.
Lattanzio M, Ferrari M, Martini S, Ceriani F, Imporzani A, Marino F
J Med Case Rep. 2022; 16(1):385.
PMID: 36258237
PMC: 9578229.
DOI: 10.1186/s13256-022-03571-9.
Nekoukar Z, Moghimi M, Salehifar E
Blood Res. 2021; 56(4):229-242.
PMID: 34776414
PMC: 8721448.
DOI: 10.5045/br.2021.2021117.
Risk-efficacy balance of ulipristal acetate compared to surgical alternatives.
Middelkoop M, Bet P, Drenth J, Huirne J, Hehenkamp W
Br J Clin Pharmacol. 2020; 87(7):2685-2697.
PMID: 33341097
PMC: 8359338.
DOI: 10.1111/bcp.14708.
Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes.
Fardel O, Moreau A, Le Vee M, Denizot C, Parmentier Y
Eur J Drug Metab Pharmacokinet. 2018; 44(1):13-30.
PMID: 30167999
DOI: 10.1007/s13318-018-0502-x.
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension.
Monaco T, Davila C
Drug Des Devel Ther. 2016; 10:1675-82.
PMID: 27274200
PMC: 4876803.
DOI: 10.2147/DDDT.S88612.
The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction.
Chan E, Buckley B, Farraj A, Thompson L
Pharmacol Ther. 2016; 165:63-78.
PMID: 27222357
PMC: 6390286.
DOI: 10.1016/j.pharmthera.2016.05.006.
Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.
Yang K, Guo C, Woodhead J, St Claire 3rd R, Watkins P, Siler S
J Pharm Sci. 2016; 105(2):443-459.
PMID: 26869411
PMC: 4894499.
DOI: 10.1016/j.xphs.2015.11.008.
Treatment of pulmonary arterial hypertension in children.
Latus H, Delhaas T, Schranz D, Apitz C
Nat Rev Cardiol. 2015; 12(4):244-54.
PMID: 25645500
DOI: 10.1038/nrcardio.2015.6.
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.
de Zeeuw D, Coll B, Andress D, Brennan J, Tang H, Houser M
J Am Soc Nephrol. 2014; 25(5):1083-93.
PMID: 24722445
PMC: 4005314.
DOI: 10.1681/ASN.2013080830.
Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist E, Gillies H, Smith W, Hao J, Hubert C, St Claire 3rd R
PLoS One. 2014; 9(1):e87548.
PMID: 24498134
PMC: 3907537.
DOI: 10.1371/journal.pone.0087548.
Iontophoresis of endothelin receptor antagonists in rats and men.
Roustit M, Blaise S, Arnaud C, Hellmann M, Millet C, Godin-Ribuot D
PLoS One. 2012; 7(7):e40792.
PMID: 22808263
PMC: 3396598.
DOI: 10.1371/journal.pone.0040792.
An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.
Vitiello M, Abuchar A, Santana N, Dehesa L, Kerdel F
J Clin Aesthet Dermatol. 2012; 5(7):33-43.
PMID: 22798974
PMC: 3396456.
